FDA Person
FDAMariza Jafary
View detailed information about Mariza Jafary, including compliance records, violations, and related data.
Person Profile
FDA investigator.
Documents (12)
- WARNING LETTER · Stason Pharmaceuticals, Inc. · October 25, 2019
- WARNING LETTER · DSP Skin Care LLC · September 9, 2021
- WARNING LETTER · Central Admixture Pharmacy Services, Inc. · August 25, 2023
- WARNING LETTER · Alphatec Spine, Inc. · February 11, 2010
- WARNING LETTER · Center for Fertility and Gynecology · June 24, 2008
- WARNING LETTER · First Pharma Associates LLC dba Riverpoint Pharmacy · December 16, 2016
- WARNING LETTER · Conversio Health · September 25, 2019
- 483 RESPONSE · Civic Center Pharmacy, Inc. · October 9, 2014
- AMENDED 483 · California Pharmacy & Compounding Center · December 7, 2018
- STATE REFERRAL LETTER · Hartley Medical Center Pharmacy, Incorporated · March 24, 2017
- STATE REFERRAL LETTER · Auro Pharmacies, Inc. · August 8, 2022
- STATE REFERRAL LETTER · First Pharma Associates LLC dba Riverpoint Pharmacy · February 23, 2021
Person Information
Name
Mariza Jafary
Role
Regulatory Personnel
ID: 307fe792-b470-40dd-b29a-40d8b631bf4e
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.